Labcorp price target raised to $300 from $285 at Baird

Baird raised the firm’s price target on Labcorp to $300 from $285 and keeps an Outperform rating on the shares. The analyst said expectations were low heading into results and although there was a guidance miss, it seems there is a plausible bridge to calmer times and valuation does not appear demanding.